Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06789757
Title The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC) ((HCC))
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Inova Health Care Services
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.